TK-685 is an orally active, selective, allosteric SHP2 inhibitor with an IC50 of 2.1 nM. It targets the SHP2-mediated AKT and ERK signaling pathways to inhibit the proliferation of esophageal cancer cells and induce apoptosis (apoptosis).
Target:
Phosphatase
* VAT and and shipping costs not included. Errors and price changes excepted
